Jayakumar Rajadas

This inventor holds 29 USPTO granted patents and 29 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Biomaterial Delivery Systems. Top assignees: Leland Stanford Junior University, The United States Government as Represented by the Department of Veterans Affairs, Allergan Holdings France S.a.s.. Active years: 2012-2026.

USPTO Granted Patents = 29 (Patent Applications = 29)

% Patents Active = 72.4

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 136(Granted Patents)

Location History:

Stanford, CA (US) (2012 - 2021)
Cupertino, CA (US) (2012 - 2022)

Company Filing History:

23 out of 5,501

Leland Stanford Junior University

patents

6 out of 955

The United States Government as Represented by the Department of Veterans Affairs

patents

4 out of 6

Allergan Holdings France S.a.s.

patents

4. 3 out of 3,795

Johns Hopkins University

Children's Hospital & Research Center Oakland

patents

7. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Stem Cell Delivery

Hydrogel Formulations

Transdermal Delivery

HIF-1 Modulators

Biochemical Detection

Immune Modulation

Collagen Production

Microneedle Patches

Pulmonary Hypertension

Iron Chelators

Allergen Sensitivity

Hyaluronic Acid

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709735 - EFFICIENT STEM CELL DELIVERY INTO BIOMATERIALS USING CAPILLARY DRIVEN ENCAPSULATION (2026-08-18),

2. 12178940 - Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation (2024-12-31),

3. 11400049 - Pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases (2022-08-02),

4. 11174460 - Efficient stem cell delivery into biomaterials using capillary driven encapsulation (2021-11-16),

5. 11160775 - Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds (2021-11-02),

6. 11154484 - Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof (2021-10-26),

7. 11013899 - Microneedle patches for transdermal delivery (2021-05-25),

8. 10751304 - Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds (2020-08-25),

9. 10548860 - HIF-1 modulator paint formulation and uses thereof (2020-02-04),

10. 10527577 - Nanogrid electrochemical sensor for detection of biochemical species by electrochemical impedance spectroscopy (2020-01-07),

11. 10463595 - Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof (2019-11-05),

12. 10426403 - Methods of testing for allergen sensitivity (2019-10-01),

13. 10370400 - 4-methylumbelliferone derivatives for treatment for immune modulation (2019-08-06),

14. 10220009 - HIF-1 modulator paint formulation and uses thereof (2019-03-05),

15. 10098857 - Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds (2018-10-16),

Title: The Innovative Journey of Jayakumar Rajadas

Introduction: Jayakumar Rajadas is a renowned inventor based in Cupertino, CA, known for his groundbreaking contributions to the field of medical technology and biotechnology.

Latest Patents: Jayakumar Rajadas holds several patents in the areas of drug delivery systems, biomaterials, and medical devices, with his most recent patent focusing on a novel method for targeted drug delivery to cancer cells.

Career Highlights: With a background in biomedical engineering and a Ph.D. in Bioengineering, Jayakumar Rajadas has had a distinguished career working in both academia and industry. He has held key research positions at leading research institutions and has been instrumental in developing innovative solutions for complex medical challenges.

Collaborations: Throughout his career, Jayakumar Rajadas has collaborated with top researchers, medical professionals, and industry experts to bring cutting-edge technologies from the lab to the market. His collaborative efforts have resulted in the successful commercialization of several medical devices and therapies.

Conclusion: Jayakumar Rajadas continues to be a driving force in the field of medical innovation, with his passion for improving patient outcomes evident in his groundbreaking inventions and patents. His dedication to advancing healthcare through technology makes him a true pioneer in the industry.